Clinical Trial Update: Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the optimal insulin correction factor for managing post-exercise hyperglycemia in adults with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: UNKNOWN